dr. Emiel De Jaeghere (MD, PhD)

Emiel De Jaeghere is dedicated to improving outcomes for women with gynecological cancers through high-quality care and research. His work focuses on advancing treatment options and enhancing the clinical management of gynecological cancer.
 

Emiel De Jaeghere graduated as a medical doctor (summa cum laude) in 2018 from Ghent University, Belgium. With a strong passion for scientific research, he pursued a PhD, supported by the Research Foundation-Flanders, at the Laboratory of Experimental Cancer Research (Ghent University) and the Department of Medical Oncology at Ghent University Hospital. His research, focused on the tumor immune microenvironment, was conducted under the guidance of Prof. Dr. Hannelore Denys, Prof. Dr. Olivier De Wever, and Prof. Dr. Frédéric Amant. Emiel successfully defended his PhD in 2025.

Throughout his training, Emiel developed a specific interest in the treatment of gynecological cancers, including cervical, endometrial, and ovarian cancers, as well as rarer types. To expand his expertise in this field, he completed internships at renowned oncology hospitals, such as Kliniken Essen-Mitte (Essen, Germany), the Institut Jules Bordet (Brussels, Belgium), and Erasmus MC (Rotterdam, The Netherlands). As a laureate of the 2024 Horlait-Dapsens Grant, he is currently completing a one-year specialization program at the Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital (Amsterdam, The Netherlands).

Emiel is the co-author of more than 20 PubMed-indexed publications and remains an active member of several professional societies, reflecting his ongoing commitment to advancing gynecological cancer research and treatment.
 

• Splenic hematopoietic and stromal cells in cancer progression. Cancer Research. 2020;81(2):27-34. (IF2020=12.701; Journal ranking in ‘Oncology’: 17/242, Q1)
• Treatment of ovarian cancer with intraperitoneal platinum: Heating up the debate. Journal of Clinical Oncology. 2019;37(33):3169-3170. (IF2019=32.956; Journal ranking in ‘Oncology’: 5/244, Q1)
• Fibroblasts fuel immune escape in the tumor microenvironment. Trends in Cancer. 2019;5(11):704-723. (IF2019=11.093; Journal ranking in ‘Oncology’: 13/244, Q1)
• Heterocellular 3D scaffolds as biomimetic to recapitulate the tumor microenvironment of peritoneal metastases in vitro and in vivo. Biomaterials. 2018;158:95-105. (IF2018=10.273; Journal ranking in ‘Materials Science, Biomaterials’: 1/32, Q1)
• Link to all publications  of Emiel De Jaeghere via PubMed
   

• Lab address: Department of Medical Oncology (Route 535; entrance 56), Ghent University Hospital, C. Heymanslaan 10, B-9000, Ghent, Belgium
• Researchgate 
• LinkedIn
• X (former Twitter)
• Academic Bibliography 
• Emiel De Jaeghere is interested to receive invitations for presentations or talks